If you’re on the fence about investing in Amedisys, Inc., LifeStance Health Group or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making ...

The chart above depicts the trend in analyst earnings per share (EPS) forecasts for Amedisys Inc for the upcoming quarter. Analysts have reduced this quarter's expectations by -12.1% for EPS from 1.21 ...

For the quarter ended December 2024, Amedisys (AMED) reported revenue of $598.05 million, up 4.8% over the same period last year. EPS came in at $0.96, compared to $0.94 in the year-ago quarter.

BATON ROUGE, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2024. Three-Month Periods ...

Adam Rothbarth was the former Food & Kitchen Writer for VICE's shopping page, Rec Room, and contributes to Chicago Magazine, Eater, and more. This big, insulated tumbler has all the features that ...

Amedisys Inc. (Nasdaq: AMED) experienced growth in home health during the fourth quarter of 2024, despite incurring merger-related costs from its pending acquisition by UnitedHealth Group (NYSE: UNH).

Amedisys (AMED) came out with quarterly earnings of $0.96 per share, missing the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $0.94 per share a year ago. These figures ...

In light of the pending merger of the Company with UnitedHealth Group Incorporated, Amedisys will not conduct a quarterly earnings call to discuss the fourth quarter and year end results.

(2) Adjusted EBITDA is defined as net (loss) income attributable to Amedisys, Inc. before net interest expense, provision for income taxes and depreciation and amortization, excluding certain items as ...

The number of estimates provides a feel for the depth of coverage for a company. This quarter, Amedisys, Inc.’s stock missed analyst predictions for earnings per share during the Q1. This consensus ...